HLX in AML: novel prognostic and therapeutic target

Oncotarget. 2012 Oct 11;3(10):1059-60. doi: 10.18632/oncotarget.705. Print 2012 Oct.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Animals
  • Homeodomain Proteins / biosynthesis*
  • Humans
  • Leukemia, Myeloid, Acute / drug therapy*
  • Leukemia, Myeloid, Acute / metabolism*
  • Mice
  • Molecular Targeted Therapy
  • Prognosis
  • Transcription Factors / biosynthesis*
  • Treatment Outcome

Substances

  • HLX protein, human
  • Hlx protein, mouse
  • Homeodomain Proteins
  • Transcription Factors